Patent Could Help Virginia Commonwealth University Breathe Easier
from Richmond Biz Sense
An invention developed at Virginia Commonwealth University is making its way to the private sector. VCU last week announced a licensing agreement with a New Jersey pharmaceutical company that will look to take a medication developed by a VCU professor to market, which could mean a windfall for the school. As part of the deal, Nostrum Pharmaceuticals gets the rights to a patent application submitted by VCU for an inhaled medication that might someday be used to treat respiratory diseases. In exchange, the school would get milestone payments and royalties, should the medicine make it to commercial production. Bruce Rubin, a professor and chair of pediatrics at the VCU Medical Center, patented a process to show that a medication called dapsone, in an inhaled form, can clear lung inflammation. Dapsone is an antibiotic that is typically used to treat leprosy, according to VCU.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063